These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 17285097

  • 1. Citalopram versus amitriptyline in elderly depressed patients with or without mild cognitive dysfunction: a danish multicentre trial in general practice.
    Rosenberg C, Lauritzen L, Brix J, Jørgensen JB, Kofod P, Bayer LB.
    Psychopharmacol Bull; 2007; 40(1):63-73. PubMed ID: 17285097
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder.
    Langworth S, Bodlund O, Agren H.
    J Clin Psychopharmacol; 2006 Apr; 26(2):121-7. PubMed ID: 16633139
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.
    Fraguas R, da Silva Telles RM, Alves TC, Andrei AM, Rays J, Iosifescu DV, Wajngarten M.
    Contemp Clin Trials; 2009 May; 30(3):205-11. PubMed ID: 19470312
    [Abstract] [Full Text] [Related]

  • 5. A prospective study of escitalopram in the treatment of major depressive episodes in the presence or absence of anxiety.
    Olié JP, Tonnoir B, Ménard F, Galinowski A.
    Depress Anxiety; 2007 May; 24(5):318-24. PubMed ID: 17041922
    [Abstract] [Full Text] [Related]

  • 6. A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injury.
    Rapoport MJ, Mitchell RA, McCullagh S, Herrmann N, Chan F, Kiss A, Feinstein A, Lanctôt KL.
    J Clin Psychiatry; 2010 Sep; 71(9):1125-30. PubMed ID: 20441723
    [Abstract] [Full Text] [Related]

  • 7. Escitalopram versus placebo in the treatment of dysthymic disorder.
    Hellerstein DJ, Batchelder ST, Hyler S, Arnaout B, Toba C, Benga I, Gangure D.
    Int Clin Psychopharmacol; 2010 May; 25(3):143-8. PubMed ID: 21811192
    [Abstract] [Full Text] [Related]

  • 8. A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder.
    von Knorring AL, Olsson GI, Thomsen PH, Lemming OM, Hultén A.
    J Clin Psychopharmacol; 2006 Jun; 26(3):311-5. PubMed ID: 16702897
    [Abstract] [Full Text] [Related]

  • 9. Escitalopram in the treatment of anxiety symptoms associated with depression.
    Bandelow B, Andersen HF, Dolberg OT.
    Depress Anxiety; 2007 Jun; 24(1):53-61. PubMed ID: 16937393
    [Abstract] [Full Text] [Related]

  • 10. A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.
    Boulenger JP, Huusom AK, Florea I, Baekdal T, Sarchiapone M.
    Curr Med Res Opin; 2006 Jul; 22(7):1331-41. PubMed ID: 16834832
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram.
    Allard P, Gram L, Timdahl K, Behnke K, Hanson M, Søgaard J.
    Int J Geriatr Psychiatry; 2004 Dec; 19(12):1123-30. PubMed ID: 15526307
    [Abstract] [Full Text] [Related]

  • 12. [A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression].
    Möslinger-Gehmayr R, Zaninelli R, Contu A, Oberhoff C, Gutschow K, Schindler AE, Staab HJ.
    Zentralbl Gynakol; 2000 Dec; 122(4):195-202. PubMed ID: 10795116
    [Abstract] [Full Text] [Related]

  • 13. Escitalopram in the treatment of major depressive disorder in primary-care settings: an open-label trial.
    Chokka P, Legault M.
    Depress Anxiety; 2008 Dec; 25(12):E173-81. PubMed ID: 19006260
    [Abstract] [Full Text] [Related]

  • 14. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
    Bose A, Korotzer A, Gommoll C, Li D.
    Depress Anxiety; 2008 Dec; 25(10):854-61. PubMed ID: 18050245
    [Abstract] [Full Text] [Related]

  • 15. An open-label multicentric study of the tolerability and response to escitalopram treatment in Indian patients with major depressive disorder.
    Pinto C, Trivedi JK, Vankar GK, Sharma PS, Narasimha V.
    J Indian Med Assoc; 2007 Jul; 105(7):364, 366, 368 passim. PubMed ID: 18178988
    [Abstract] [Full Text] [Related]

  • 16. Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial.
    Kok RM, Nolen WA, Heeren TJ.
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1247-54. PubMed ID: 17562523
    [Abstract] [Full Text] [Related]

  • 17. [Citalopram (Cipramil) in monotherapy of depressed outpatients].
    Landowski J.
    Psychiatr Pol; 2000 Dec; 34(3 Suppl):1-8. PubMed ID: 11055187
    [Abstract] [Full Text] [Related]

  • 18. Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study.
    Khajavi D, Farokhnia M, Modabbernia A, Ashrafi M, Abbasi SH, Tabrizi M, Akhondzadeh S.
    J Clin Psychiatry; 2012 Nov; 73(11):1428-33. PubMed ID: 23146150
    [Abstract] [Full Text] [Related]

  • 19. Double-blind comparison of venlafaxine and amitriptyline in outpatients with major depression with or without melancholia.
    Gentil V, Kerr-Correa F, Moreno R, D'Arrigo Busnello E, De Campos JA, Juruena MF, Lafer B, Moreno DH, De Cassia Rodrigues RL, Tiosso A, Benedictis E.
    J Psychopharmacol; 2000 Mar; 14(1):61-6. PubMed ID: 10757255
    [Abstract] [Full Text] [Related]

  • 20. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
    Otsubo T, Akimoto Y, Yamada H, Koda R, Aoyama H, Tanaka K, Mimura M, Nakagome K, Kamijima K.
    Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.